| : Lancet 2001 May 5;357(9266):1451 |
Related Articles,
|
T cells and vaccination.
Jefferys R.
Publication Types:
Sir--In the debate about the safety of infant vaccinations,1 a potentially critical issue seems to have gone almost unmentioned. Accumulating evidence suggests that the mechanisms underlying the maintenance of T-cell homoeostasis are intimately involved in preventing the undesired expansion of self-reactive T cells and resultant autoimmune disease. Most importantly, the continuous export of naïve T cells from the thymus seems to be key in controlling the number of self-reactive peripheral T cells, according to Tanchot and Rocha.2
What might the relevance of this observation be to infant vaccinations and autoimmune disease? It could be two-fold. First, administration of multiple vaccines in a short space of time will probably lead to a large, albeit transient, depletion of naïve T cells as vaccine-antigen-specific cells are primed and undergo activation-induced cell death or differentiate into memory T cells. On the basis of current models of T-cell homoeostasis, this lesion in the naïve- T-cell pool will allow extended survival of naïve T cells not specific for vaccine antigens, which will potentially include autoreactive naïve T cells. Thus, the future risk of autoimmune disease could be increased.
Second, accumulation of high numbers of apoptotic cells is proposed to lead to immunogenic presenta- tion of intracellular self-antigens and thereby trigger automimune responses.3 Although a subset of T cells activated by vaccine antigens mature into memory T cells, most will undergo expansion followed by apoptosis driven by activation-induced cell death. Multiple vaccinations during a short space of time could therefore also increase the risk of immunogenic presentation of intracellular self-antigens by increasing the number of T cells undergoing apoptosis.
These possibilities do not seem to have been specifically investigated in animals. Before any immunisation is declared safe, the potential disruption in normal T cell homoeostasis--and any resultant adverse outcomes--must be fully assessed. For infants, whose immune system is still maturing, such ill-understood issues should be a public-health priority.
Richard Jefferys
--------------------------------------------------------------------------------
AIDS Treatment Data Network, 611 Broadway, Suite 613, New York, NY 10012, USA
1 Editorial. Measles, MMR, and autism: the confusion continues. Lancet 2000; 355: 1379.
2 Tanchot C, Rocha B. Peripheral selection of T cell repertoires: the role of continuous thymus output. J Exp Med 1997; 186: 1099-106. [PubMed]
3 Rovere P, Vallinoto C, Bondanza A, et al. Cutting edge: bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 1998; 161: 4467-71. [PubMed]
PMID: 11360958 [PubMed - indexed for MEDLINE]
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.